Rifaximin for the Secondary Prevention of Recurrent Pouchitis
Clinical trial NCT06312683 · RECRUITING
Trial details
- NCT number
- NCT06312683
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.